Meeting
2020 ASCO Virtual Scientific Program
A novel gene signature for predicting response to chemoradiotherapy in locally advanced esophageal adenocarcinoma.
Authors
Divya Sahu
Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope, Monrovia, CA
Divya Sahu , Ashten N. Omstead , Anastasia Gorbunova , Dennis O’Meally , Madison Salvitti , Vincent K. Lam , Blair A Jobe , Ronan Joseph Kelly , Ajay Goel , Ali Hussainy Zaidi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Citation
J Clin Oncol 38: 2020 (suppl; abstr 4571)
DOI
10.1200/JCO.2020.38.15_suppl.4571
Abstract #
4571
Poster Bd #
179
Abstract Disclosures
Similar Posters
Poster
2019 Gastrointestinal Cancers Symposium
Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma.
First Author: Laila Babar
Poster
2017 ASCO Annual Meeting
Magnitude and duration of immune checkpoint up-regulation and changes in the immune microenvironment post chemo-radiation (CRT) in esophageal cancer.
First Author: Ronan Joseph Kelly
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Transcriptomic profiling to identify subsets of immune hot locally advanced rectal adenocarcinomas with favorable outcomes after neoadjuvant treatment.
First Author: Francisco Sanchez Vega
Poster
2021 Gastrointestinal Cancers Symposium
Selecting the optimal neoadjuvant treatment approach based on the risk of an involved surgical margin in locally advanced adenocarcinoma of the esophagus and esophagogastric junction.
First Author: Tim Spencer